Collegium Pharmaceutical Inc

Collegium Pharmaceutical Inc (COLL) Becoming More Attractive for Investors

Daniel Torres

Collegium Pharmaceutical Inc’s recent filing unveils that its Director Fallon John A. unloaded Company’s shares for reported $1.65 million on ...

Analysts review Collegium Pharmaceutical Inc’s rating

Samantha Gray

Collegium Pharmaceutical Inc’s recently made public that its EVP & Chief Financial Officer Tupper Colleen unloaded Company’s shares for reported ...

COLL stock price expected to increase by 38 in 12 months

Daniel Torres

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Collegium Pharmaceutical ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.